Jeff Liter

Jeff is a seasoned CEO with a proven track record at profitably growing emerging companies and business divisions. He has raised over $10M in seed capital from angel investors to start four different companies which he then led to becoming profitable or acquired. At his time at PCT as their COO, he supported over 20 clinical trials in the Cell and Gene Therapy field. These trials ranged from Phase I to Phase III pivotal trials.